SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-24-033564
Filing Date
2024-04-16
Accepted
2024-04-16 21:09:20
Documents
1
Period of Report
2024-04-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 7751
  Complete submission text file 0001213900-24-033564.txt   9491
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Issuer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 244, GALMACHI-RO, JUNGWON-GU SEONGNAM-SI, GYEONGGI-DO M5 13211
Business Address 244, GALMACHI-RO, JUNGWON-GU SEONGNAM-SI, GYEONGGI-DO M5 13211 82-2-550-8800
Daewoong Co., Ltd (Reporting) CIK: 0001985493 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-40021 | Film No.: 24849141